Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1254

1.

Impact of female sex on lipid lowering, clinical outcomes, and adverse effects in atorvastatin trials.

Hsue PY, Bittner VA, Betteridge J, Fayyad R, Laskey R, Wenger NK, Waters DD.

Am J Cardiol. 2015 Feb 15;115(4):447-53. doi: 10.1016/j.amjcard.2014.11.026. Epub 2014 Nov 29.

PMID:
25637322
2.

Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease.

van de Woestijne AP, van der Graaf Y, Westerink J, Nathoe HM, Visseren FL.

Am J Cardiol. 2015 Feb 15;115(4):441-6. doi: 10.1016/j.amjcard.2014.11.021. Epub 2014 Nov 29.

PMID:
25554536
3.

Safety profile of subjects treated to very low low-density lipoprotein cholesterol levels (<30 mg/dl) with rosuvastatin 20 mg daily (from JUPITER).

Everett BM, Mora S, Glynn RJ, MacFadyen J, Ridker PM.

Am J Cardiol. 2014 Dec 1;114(11):1682-9. doi: 10.1016/j.amjcard.2014.08.041. Epub 2014 Sep 16.

PMID:
25439449
4.

Clinical pharmacology of albiglutide, a GLP-1 receptor agonist.

Young MA, Wald JA, Matthews JE, Scott R, Hodge RJ, Zhi H, Reinhardt RR.

Postgrad Med. 2014 Nov;126(7):84-97. doi: 10.3810/pgm.2014.11.2836. Review.

PMID:
25387217
5.

Vascular injury in diabetic db/db mice is ameliorated by atorvastatin: role of Rac1/2-sensitive Nox-dependent pathways.

Bruder-Nascimento T, Callera GE, Montezano AC, He Y, Antunes TT, Cat AN, Tostes RC, Touyz RM.

Clin Sci (Lond). 2015 Apr;128(7):411-23. doi: 10.1042/CS20140456.

PMID:
25358739
6.

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.

Swerdlow DI, Preiss D, Kuchenbaecker KB, Holmes MV, Engmann JE, Shah T, Sofat R, Stender S, Johnson PC, Scott RA, Leusink M, Verweij N, Sharp SJ, Guo Y, Giambartolomei C, Chung C, Peasey A, Amuzu A, Li K, Palmen J, Howard P, Cooper JA, Drenos F, Li YR, Lowe G, Gallacher J, Stewart MC, Tzoulaki I, Buxbaum SG, van der A DL, Forouhi NG, Onland-Moret NC, van der Schouw YT, Schnabel RB, Hubacek JA, Kubinova R, Baceviciene M, Tamosiunas A, Pajak A, Topor-Madry R, Stepaniak U, Malyutina S, Baldassarre D, Sennblad B, Tremoli E, de Faire U, Veglia F, Ford I, Jukema JW, Westendorp RG, de Borst GJ, de Jong PA, Algra A, Spiering W, Maitland-van der Zee AH, Klungel OH, de Boer A, Doevendans PA, Eaton CB, Robinson JG, Duggan D; DIAGRAM Consortium; MAGIC Consortium; InterAct Consortium, Kjekshus J, Downs JR, Gotto AM, Keech AC, Marchioli R, Tognoni G, Sever PS, Poulter NR, Waters DD, Pedersen TR, Amarenco P, Nakamura H, McMurray JJ, Lewsey JD, Chasman DI, Ridker PM, Maggioni AP, Tavazzi L, Ray KK, Seshasai SR, Manson JE, Price JF, Whincup PH, Morris RW, Lawlor DA, Smith GD, Ben-Shlomo Y, Schreiner PJ, Fornage M, Siscovick DS, Cushman M, Kumari M, Wareham NJ, Verschuren WM, Redline S, Patel SR, Whittaker JC, Hamsten A, Delaney JA, Dale C, Gaunt TR, Wong A, Kuh D, Hardy R, Kathiresan S, Castillo BA, van der Harst P, Brunner EJ, Tybjaerg-Hansen A, Marmot MG, Krauss RM, Tsai M, Coresh J, Hoogeveen RC, Psaty BM, Lange LA, Hakonarson H, Dudbridge F, Humphries SE, Talmud PJ, Kivimäki M, Timpson NJ, Langenberg C, Asselbergs FW, Voevoda M, Bobak M, Pikhart H, Wilson JG, Reiner AP, Keating BJ, Hingorani AD, Sattar N.

Lancet. 2015 Jan 24;385(9965):351-61. doi: 10.1016/S0140-6736(14)61183-1. Epub 2014 Sep 24.

7.

Statins and type 2 diabetes: genetic studies on target.

Frayling TM.

Lancet. 2015 Jan 24;385(9965):310-2. doi: 10.1016/S0140-6736(14)61639-1. Epub 2014 Sep 24. No abstract available.

8.

Ask the doctor. I've heard that taking statins can raise your risk of diabetes. Is this really true?

Bhatt DL.

Harv Heart Lett. 2014 Jul;24(11):2. No abstract available.

PMID:
25185274
9.

[Impacts of atorvastatin on blood lipids and arterial media thickness in new-onset type 2 diabetes patients].

Yu D, Wang Y, Chi J, Sun M, Guo L, Jiang L, Li M, Li H, Pan Q, Wang X, Xian T.

Zhonghua Liu Xing Bing Xue Za Zhi. 2014 Jun;35(6):733-6. Chinese.

PMID:
25174483
10.

[A critical appraisal of the European guidelines on diabetes, pre-diabetes and cardiovascular diseases].

Miccoli R.

G Ital Cardiol (Rome). 2014 Jun;15(6):350-4. doi: 10.1714/1582.17276. Italian. No abstract available.

PMID:
25072420
11.

Statins on trial. Pfizer faces clot of lawsuits that claim Lipitor caused women's diabetes.

Carlson J.

Mod Healthc. 2014 May 19;44(20):20-2. No abstract available.

PMID:
25055462
12.

Statin therapy in women.

Shufelt CL, Manson JE, American College of Cardiology.

Menopause. 2014 Aug;21(8):896-8. doi: 10.1097/GME.0000000000000317.

PMID:
25055048
13.

Impaired fibrous repair: a possible contributor to atherosclerotic plaque vulnerability in patients with type II diabetes.

Edsfeldt A, Gonçalves I, Grufman H, Nitulescu M, Dunér P, Bengtsson E, Mollet IG, Persson A, Nilsson M, Orho-Melander M, Melander O, Björkbacka H, Nilsson J.

Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2143-50. doi: 10.1161/ATVBAHA.114.303414. Epub 2014 Jul 17.

PMID:
25035341
14.

Effects of pitavastatin versus atorvastatin on the peripheral endothelial progenitor cells and vascular endothelial growth factor in high-risk patients: a pilot prospective, double-blind, randomized study.

Lin LY, Huang CC, Chen JS, Wu TC, Leu HB, Huang PH, Chang TT, Lin SJ, Chen JW.

Cardiovasc Diabetol. 2014 Jul 16;13:111. doi: 10.1186/s12933-014-0111-1.

15.

Statins and the risk of type 2 diabetes mellitus: cohort study using the UK clinical practice pesearch datalink.

Macedo AF, Douglas I, Smeeth L, Forbes H, Ebrahim S.

BMC Cardiovasc Disord. 2014 Jul 15;14:85. doi: 10.1186/1471-2261-14-85.

16.

Re: Lovastatin for reduction of leptin in nondialysis patients with type 2 diabetic nephropathy.

Ahmadi F, Mohebi-Nejad A.

Iran J Kidney Dis. 2014 Jul;8(4):344-5. No abstract available.

17.

[Risk of type 2 diabetes mellitus associated with statin therapy: evidence and possible mechanisms].

Suazo J, Rigotti A.

Rev Med Chil. 2014 Feb;142(2):222-8. doi: 10.4067/S0034-98872014000200011. Review. Spanish.

18.

The effects of statin use on the development of tuberculosis among patients with diabetes mellitus.

Kang YA, Choi NK, Seong JM, Heo EY, Koo BK, Hwang SS, Park BJ, Yim JJ, Lee CH.

Int J Tuberc Lung Dis. 2014 Jun;18(6):717-24. doi: 10.5588/ijtld.13.0854.

PMID:
24903944
19.

Lovastatin for reduction of leptin in nondialysis patients with type 2 diabetic nephropathy.

Gholamin S, Razavi SM, Taghavi-Garmestani SM, Ghorbanihaghjo A, Rashtchizadeh N, Safa J, Vatankhah AM, Azizi T, Argani H.

Iran J Kidney Dis. 2014 May;8(3):201-6.

20.

Statins and diabetes.

Hitman GA.

Diabet Med. 2014 Jun;31(6):639. doi: 10.1111/dme.12463. No abstract available.

PMID:
24835891
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk